Emergency: livtencity medication for kidney transplant infection
Ended Awarded Last action
- Contract number
- 36C24122F0125
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $40,408
Award facts
- Contract value 100% obligated
- $40,407.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- West Haven, CT 06516, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $2,971 | |
| Original award | $37,437 |
About this award
This is a firm fixed-price delivery order under Takeda Pharmaceuticals America Inc.'s General Services Administration (GSA) Pharmaceuticals and Drugs Schedule contract. The order, valued at $40,407.82, is for the emergency procurement of LIVTENCITY medication to treat kidney transplant infections. The contract was awarded on February 28, 2022, by the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs (VA), and has an ultimate completion date of November 30, 2024. Takeda Pharmaceuticals America Inc. is the prime contractor for this award, which is not set aside for any particular business category. As a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America Inc. is a key supplier of specialized medications to various federal agencies, including the VA, Department of Justice Bureau of Prisons, and Department of Defense.
Quick answers
Who was awarded contract 36C24122F0125?
36C24122F0125 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on February 28, 2022.
How much is contract 36C24122F0125 worth?
The government has obligated $40,408 on 36C24122F0125.
Is contract 36C24122F0125 an order under another contract?
Yes. 36C24122F0125 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24122F0125 competed?
The extent of competition for 36C24122F0125 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award